Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Femoral Vascular Closure Devices After Catheterization Procedure

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Femoral Vascular Closure Devices After Catheterization Procedure

Syed Mohammad Haleem et al.
Free Books & Documents

Excerpt

Cardiac catheterization is often required for various procedures, including angiography, angioplasty, valve replacement, valvuloplasty, ablation, and congenital heart repair. This procedure is necessary to assess and care for many patients presenting with myocardial infarction, heart disease, valvular disease, or congenital heart disease—with a common site of catheterization entry being the femoral artery. Catheterization is a procedure that is heavily performed in the field of interventional cardiology. After catheterization procedures, appropriate mechanisms are necessary to close the port of entry of the catheter into the femoral artery. As a result, the need for devices to assist in closing the femoral artery is continually evolving.

Initially, the only mechanism to assist in hemostasis at the catheter insertion site would be mechanical compression of the femoral artery. Although mechanical compression is sufficient in patients without certain comorbidities, it can be challenging in patients who are obese and on anticoagulation therapy. Additionally, patients treated through femoral access require a longer hospital stay than those who receive radial access. Manual compression would take longer to achieve hemostasis, increasing the strain on the healthcare system. Certain procedures, such as inserting left ventricular assist devices and mitral/aortic valve replacement procedures, require larger femoral vascular access sites, making mechanical compression cumbersome or a less effective method to achieve hemostasis.

Femoral vascular closure devices can be divided into 2 broad categories: passive and active. Passive closure devices help achieve mechanical compression and reduce thrombosis to achieve effective hemostasis. However, passive devices do not hasten the time it takes to reach hemostasis. Active closure devices include suture devices, collagen plugs, and clips.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Syed Mohammad Haleem declares no relevant financial relationships with ineligible companies.

Disclosure: Sara Collier declares no relevant financial relationships with ineligible companies.

Disclosure: Pradyumna Agasthi declares no relevant financial relationships with ineligible companies.

References

    1. Noori VJ, Eldrup-Jørgensen J. A systematic review of vascular closure devices for femoral artery puncture sites. J Vasc Surg. 2018 Sep;68(3):887-899. - PubMed
    1. Robertson L, Andras A, Colgan F, Jackson R. Vascular closure devices for femoral arterial puncture site haemostasis. Cochrane Database Syst Rev. 2016 Mar 07;3(3):CD009541. - PMC - PubMed
    1. Zlotorowicz M, Czubak-Wrzosek M, Wrzosek P, Czubak J. The origin of the medial femoral circumflex artery, lateral femoral circumflex artery and obturator artery. Surg Radiol Anat. 2018 May;40(5):515-520. - PMC - PubMed
    1. Goldsweig AM, Secemsky EA. Vascular Access and Closure for Peripheral Arterial Intervention. Interv Cardiol Clin. 2020 Apr;9(2):117-124. - PubMed
    1. Kiesz RS, Wiernek BK, Wiernek SL, Merritt C, Ybarra T, Iwanski A, Buszman PP, Szymanski R, Martin JL, Buszman PE. Cardiva Catalyst II vascular access management device in percutaneous diagnostic and interventional procedures with same-day discharge (Catalyst II trial). J Endovasc Ther. 2011 Feb;18(1):46-53. - PubMed

Publication types

LinkOut - more resources